CRISPR Therapeutics Tokenized Stock (Reality) RCRSP
Rank: 10109RCRSP Price
$ 50.94
Price Range
- Low
- 24H
- High
- $ 50.02
- $ 51.81
General Info
Contracts/Explorers
-
Arbitrum One
0x335...f88c0
-
Morph L2
0xbc7...65f16
- https://arbiscan.io/token/0x33587ee65ff7b77088c5d1352425a745474f88c0
- https://intel.arkm.com/explorer/token/
- https://morphl2.socialscan.io/token/0xbc797f2543e8a2243cfbc245371283ed9e965f16
- https://intel.arkm.com/explorer/token/crispr-therapeutics-rstock
- https://explorer.morphl2.io/token/0xbc797f2543e8a2243cfbc245371283ed9e965f16
Categories
CRISPR Therapeutics Tokenized Stock (Reality) Info
CRISPR Therapeutics Tokenized Stock (Reality) (RCRSP) Chart
RCRSP Price Statistics
Market Cap
$ 7.09K
FDV
$ 7.09K
Volume (24h)
$ 5.46K
Total Supply
RCRSP 139.23
Circulating Supply
RCRSP 139.23
(100% of Total Supply)
Max Supply
RCRSP ∞
All Time High
$ 60.68 22 Sep 2026
All Time Low
$ 50.02 8 Oct 2026
About CRISPR Therapeutics Tokenized Stock (Reality) (RCRSP)
CRISPR Therapeutics AG is a clinical-stage biopharmaceutical pioneer focused on translating revolutionary Nobel Prize-winning CRISPR-Cas9 gene-editing technology into curative medical therapies. The firm's advanced R&D pipeline targets severe hemoglobinopathies (such as sickle cell disease), immuno-oncology cell therapies (CAR-T), and regenerative medicine, with its asset valuation dictated by clinical milestones and FDA approvals.
CRISPR Therapeutics Tokenized Stock (Reality) Markets
Showing
to
of
results
Rows